Despite these insights, our investigation did not observe significant changes in circadian clock gene expression, with the exception of decreased morning BMAL1 levels, pointing towards the complexity of defining circadian disruption in OSA through gene expression profiles due to heterogeneous results. The gene discussed is BMAL1; the disease is obstructive sleep apnea syndrome.